TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

Rosen Law Firm is investigating potential securities claims against Skye Bioscience, alleging false statements about nimacimab's effectiveness and clinical prospects during the period of November 4, 2024 to October 3, 2025.

Insights
SKYE   negative

The lawsuit claims the company made materially false and misleading statements about nimacimab's effectiveness, clinical prospects, and commercial potential, suggesting potential investor damages